mice-1
dra_schwartz / iStockphoto.com
29 March 2018Biotechnology

English appeals court overturns Regeneron transgenic mice decision

The English Court of Appeal has reversed a finding that two of Regeneron’s European patents covering transgenic mice were insufficient.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotechnology
3 February 2016   The English High Court has revoked two European patents owned by Regeneron Pharmaceuticals covering transgenic mice.
Biotechnology
24 June 2020   The UK Supreme Court today has sided with biopharmaceutical company Kymab, allowing its appeal in a suit involving Regeneron and patents covering transgenic mice.

More on this story

Biotechnology
3 February 2016   The English High Court has revoked two European patents owned by Regeneron Pharmaceuticals covering transgenic mice.
Biotechnology
24 June 2020   The UK Supreme Court today has sided with biopharmaceutical company Kymab, allowing its appeal in a suit involving Regeneron and patents covering transgenic mice.

More on this story

Biotechnology
3 February 2016   The English High Court has revoked two European patents owned by Regeneron Pharmaceuticals covering transgenic mice.
Biotechnology
24 June 2020   The UK Supreme Court today has sided with biopharmaceutical company Kymab, allowing its appeal in a suit involving Regeneron and patents covering transgenic mice.